Galangin for COVID-19 and Mucormycosis co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and Mucormycosis.
Galangin for COVID-19 and Mucormycosis co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and Mucormycosis.
(xsd:string)
Galangin for COVID-19 and Mucormycosis co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and Mucormycosis.
(xsd:string)